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Prostaglandin-independent protection by furosemide from oh-
guric ischemic renal failure in conscious rats. In 38 conscious rats
divided into seven groups, acute unilateral ischemic renal failure
was induced by 1 hour of complete occlusion of the left renal
artery while the contralateral kidney remained intact. Renal ex-
cretory function of the left kidney was monitored up to 144 hours
after ischemia and revealed a typical course of oliguric renal fail-
ure with oligoanuna persisting for more than 48 hours. Urinary
osmolality and sodium concentration became plasma isotonic af-
ter release of renal artery occlusion and approximated control
values on day 6 after ischemia. In nine rats, the i.v. infusion of
furosemide before (6 g/min/100 g body wt) and after (12 g/min/
100 g body wt) renal artery occlusion protected the ischemic kid-
ney from oligoanuria with endogenous creatinine clearance of
0.42 0.11 mllminlg kidney wt 5 hours after ischemia. Tubular
absorption of sodium and water was at least partially preserved
36 hours after ischemia when infusion of furosemide was
stopped. The loop diuretic significantly (P < 0.01) increased total
urinary prostaglandin (PG) E2 excretion before and after renal
artery occlusion; and 5 hours after ischemia, PGE2 excretion
from the ischemic kidney significantly exceeded that from the
intact kidney (P < 0.05). Indomethacin (1 mg/lOO g body wt) ad-
ministered in six animals markedly suppressed control PGE2 ex-
cretion (P < 0.05) as well as the furosemide-induced rise in uri-
nary PG excretion before and after ischemia but did not modify
the protective effect of the diuretic in this experimental model.
Inhibition of PG synthesis, however, reduced urinary flow rate
and sodium and potassium excretion of the contralateral intact
kidney and almost completely prevented its compensatory rise in
creatinine clearance. The results indicate that mechanisms other
than the intrarenal prostaglandin system must be considered to
mediate the protective effects of furosemide in acute ischemic
renal failure.
Protection par le furosémide, indépendante des prostaglandines,
de l'insuffisance rénale oligurique et ischémique chez le rat éveillé.
Trente huit rats éveillés, répartis en sept groupes, ont été mis en
insuffisance rénale aiguë ischémique unilatérale par occlusion
complete de l'artère rénale gauche pendant 1 heure alors que le
rein controlatéral était intact. La fonction excrétoire du rein a
été surveillée pendant 144 heures après l'ischémie et elle a subi
l'évolution typique de l'insuffisance rénale oligurique avec per-
sistance de l'oligo-anurie pendant plus de 48 heures.
L'osmolalité urinaire et Ia concentration de sodium sont de-
venues égales a celles du plasma après Ia levee de l'occlusion
artérielle rénale et se sont rapprochées des valeurs contrôles au
sixième jour après l'ischémie. Chez neuf rats Ia perfusion de fu-
rosémide avant (6 tg/min/l00 g poids corporel) et après (12 g/
min/100 g poids corporel) l'occlusion de l'artère rénale a protégé
le rein ischémique de l'oligo-anurie, avec des clearances de Ia
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créatinine de 0,42 0,11 ml/min/g de rein 5 heures après
l'ischémie. La reabsorption tubulaire de sodium et d'eau était au
moms partiellement préservée 36 heures après l'ischémie quand
la perfusion de furosémide était arrêtée. Ce diurétique augmente
significativement (P < 0,01) I'excrétion urinaire de prostaglan-
dines (PG) E2 avant et après l'occlusion de l'artère rénale; 5
heures après l'ischémie I'excrétion de PGE2 par le rein lésé est
significativement supérieure a celle du rein intact (P < 0,05).
L'indométhacine (1 mg/l00 g poids corporel) administrée a six
animaux diminue considérablement I'excrétion basale de PGE2
(P < 0,05) de mCme que l'augmentation, dépendante du furosé-
mide, de I'excrétion urinaire de PG avant et après l'ischémie,
mais ne change pas l'effet protecteur du diurétique dans ce mod-
èle experimental. L'inhibition de la synthèse de PG, cependant,
diminue le debit urinaire et l'excrétion de sodium et de po-
tassium du rein intact et empéche presque complètement
l'augmentation compensatrice de Ia clearance de Ia créatinine.
Ces résultats indiquent que d'autres mécanismes que le système
des prostaglandines intrarénales doivent étre invoqués comme
médiateurs des effets protecteurs du furosémide dans
l'insuffisance rénale aiguë ischémique.
Furosemide, a potent "high ceiling" diuretic and
renal vasodilator agent is often used in oliguria to
differentiate between established intrinsic renal fail-
ure and prerenal azotemia, but it has also been used
frequently as a preventive measure in the clinical
setting of imminent acute renal failure [1—3]. Evalu-
ation of the beneficial effects of this drug, however,
is difficult because it is not known whether condi-
tions in which protective effects of furosemide were
observed would have progressed to established ren-
al failure without its administration. Therefore, pre-
dictable conditions of experimental acute renal fail-
ure have been used to investigate a potentially pro-
tective action of this diuretic. So far, however,
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controversial results in a variety of models of exper-
imental acute renal failure in different species have
been obtained [4-Il]. Although the mechanisms of
action are not known, it was proposed that furose-
mide suppresses the signal of the macula densa
feedback system [12]. Other mechanisms, such as
an alteration in glomerular permeability [13—15], in-
creased solute excretion with shortened tubular
passage times to avoid backleak of tubular fluid and
override tubular obstruction [16], or renal vasodila-
tion [17] to increase RBF, have been discussed also.
Administration of furosemide is associated with
enhanced prostaglandin (PG) E2 release into renal
venous blood [18] and urine [19, 20]. The mecha-
nism of interaction of furosemide with renal PG,
however, is still not clear. Although in vitro studies
in rabbit papillary slices have failed to demonstrate
enhancement of PG synthesis by this drug [21], it
has been shown that furosemide might inhibit pros-
taglandin 15-OH-dehydrogenase, a major enzyme
of prostaglandin metabolism, in vitro [22, 23] and
that it may thus increase the half-life of intrarenal
PG [24, 25]. This concept has gained further support
by the observation that furosemide decreased the
excretion of the main metabolite of PGF2c, [26], sug-
gesting that it inhibits renal catabolism of PGF2,,
[26]. Increased RBF and renal PGE2 excretion fol-
lowing furosemide both can be blunted by the inhi-
bition of PG synthesis with indomethacin [18, 27].
Because the vasodilating action of furosemide
may thus be mediated by intrarenal PG, we investi-
gated this mechanism as a potential mode of pro-
tection from acute renal failure by this drug. There-
fore, the effects of furosemide on renal function and
prostaglandin E2 were studied in conscious rats
with unilateral ischemic renal failure with and with-
out inhibition of PG synthesis by indomethacin.
Methods
Female albino rats of the Sprague-Dawley strain,
each weighing 204 to 263 g, were used in this study.
All rats were fed a normal rat chow diet and had
free access to food and water. After the rats were
anesthesized with methohexital (50 mg/kg body wt,
i.p., followed by single doses of 12 mg/kg body wt,
iv, when necessary), we catheterized the jugular
vein and carotid artery (PE-50), the urinary bladder
(PE-90), and the left ureter (PE-lO) through a mid-
line abdominal incision, and we performed a 1-hour
complete occlusion of the left renal artery through a
left flank incision. After incision of the left ureter,
we inserted a PE-lO catheter 2 cm in length, con-
nected to a PE-50 catheter at one end, and we tied it
to the ureter above and below the incision to avoid
leakage of urine. After surgery, each rat was placed
in an individual restraining cage mounted on a triple
beam balance. Hourly collection of separate urine
samples from the right and the left kidney was
started 1 hour after surgery in conscious animals.
The fourth urine collection period (control period)
was followed by 1 hour of complete occlusion of the
left renal artery.
Group 1. In eight animals, renal function was
monitored before and continuously at hourly inter-
vals for 36 hours after ischemia. Thirty animals
were subdivided after 1 hour's occlusion of the left
renal artery into six groups of five animals each.
Their renal function was studied at 48, 60, 72, 96,
120, and 144 hours after ischemia. During the exper-
imental periods, the rats were infused i.v. with 2.5%
fructose at a rate of 33 to 62 p11mm to maintain a
constant body weight.
Group 2. In nine conscious rats, function of the
right (intact) and left kidney was monitored before
and for 5 hours after 1 hour's occlusion of the left
renal artery. After control collection periods, rats
were given furosemide i.v. (6 g/min/100 g) for 2
hours and were simultaneously infused with isotonic
saline to maintain a constant body weight through-
out the experiments. Furosemide infusion was
stopped for 1 hour during the left renal artery occlu-
sion and was then continued at a rate of 12 tg/min/l00
g for 5 hours after ischemia. In five animals, renal
function was monitored for 36 hours after ischemia;
furosemide and saline infusions were then stopped
and replaced by an infusion of 2.5% fructose to
maintain a constant body wt.
Group 3. Six conscious rats were treated like the
animals of group 2 except that they received indo-
methacin (10 mg/kg body wt) by stomach tube 30
mm prior to administration of furosemide and sub-
sequently every 2 hours. The function of right (in-
tact) and left kidneys was monitored separately be-
fore and for 5 hours after the left renal artery occlu-
sion.
Arterial blood pressure was monitored with a
pressure transducer (Statham P-23-Db). Urine out-
put was determined hourly. Concentrations of so-
dium and potassium were measured by flame photo-
metry, and osmolality was determined with an os-
mometer (Knauer). Creatinine concentrations in
plasma and urine were determined enzymatically by
the method of Wahlefeld, Holz, and Bergmeyer [28]
in untreated animals and in animals treated with fu-
rosemide in the absence and presence of indometh-
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Table 1. Urinary PGE2 excretion (pg/min/100 g body wt) during control periods (N = 12 rats) and during treatment with furosemide in the
absence (N = 6 rats) or presence of indomethacin (N = 6 rats) before and after 1-hour occlusion of the left renal arterya
Control
period
Before
After ischemia
ischemia 2 hr 3 hr 5 hr
Wit/i furosernide
Left kidney 19.2 6.3 64.1 9.9 35.1 11.4 41.4 9.0 126.0 18.3
pb NS <0.01 <0.05 <0.05
Right kidney 71.6 15.0 94.7 17.6 67.8 9.5 73.8 15.6
Left kidney
With Jurosemide + indornethacin
5.1 1.0 1.1 0.3 1.9 0.3 2.1 0.5
pb <0.001 <0.02 <0.01
Right kidney 21.4 6.2 3.3 0.4 7.6 1.5 4.5 1.0 5.4 1.0
Values represent the means SEM.
b Left vs. right kidney
acm before and 4 and 5 hours after ischemia. Be-
cause of the extremely small urine volumes during
these periods in untreated animals following is-
chemia, we did not measure the creatinine in the
urine from the left kidneys after renal artery occlu-
sion.
Urinary PGE2 excretion was determined in six
animals treated with furosemide and in six animals
treated with furosemide and indomethacin. For ra-
dioimmunoassay, a highly specific antirabbit PGE2
antibody was purchased from Institut Pasteur,
Paris, France, the sensitivity and specificity of
which were described in detail by Dray, Charbon-
nel, and Maclouf [29]. 3H-PGE2 was purchased
from Amersham Buchler, Braunschweig, FRG,
and unlabeled PGE2 was provided by Dr. J. Pike,
Upjohn Co., Kalamazoo, Michigan, USA. With this
antibody and a mean initial binding of 46 4%, the
lower detection limit was 2 pg of PGE2 per 0.1 ml.
Extraction of urine and chromatographic separation
were performed according to the method described
by Auletta et al [30], which resulted in a mean re-
covery of 63 8%. Urinary excretion of PGE2 is
expressed as nanograms of PGE2 per minute.
Statistical analysis of results was performed with
a double-tail Student's t test. Data are presented as
means SEM.
Results
Systemic arterial blood pressure. Mean systemic
arterial blood pressure in control rats was 116.5
5.0 mm Hg during control periods, 117.0 6.3 mm
Hg during ischemia, and 114.3 4.0 mm Hg within
5 hours after ischemia. Administration of furose-
mide in the presence or absence of indomethacin
had no effects on systemic arterial blood pressure
before (115.0 1.5 mm Hg). during (116.5 4.5
mm Hg), or following left renal arterial occlusion
(113.5 3.0mm Hg).
Urinary PGE2 excretion. Before occlusion of the
left renal artery, furosemide significantly enhanced
total urinary PGE2 excretion from 40.6 to 135.7 pg/
minJlOO g (P < 0.01) without difference between
right and left renal PGE2 excretion. Elevated uri-
nary PGE2 excretion from the right (intact) kidney
persisted with administration of furosemide after re-
lease of left renal artery occlusion, but urinary
PGE2 excretion from the left (ischemic) kidney was
significantly depressed at 2 hours after ischemia (P
<0.05). Five hours after ischemia, however, PGE2
excretion from the left (ischemic) kidney had risen
to a value significantly higher than that of the con-
tralateral (intact) kidney (P < 0.05) (Table 1). Ad-
ministration of indomethacin almost completely
suppressed preischemic total PGE2 excretion in fu-
rosemide-treated rats to 8.4 pglminllOO g (P <0.05)
without difference between right and left kidney.
Two hours following ischemia of the left kidney,
urinary PGE2 excretion from the right (intact) kid-
ney increased (P < 0.01), but PGE2 excretion from
the left (ischemic) kidney was further reduced (P <
0.001) (Table 1).
Endogenous creatinine clearance. In furosemide-
treated rats, endogenous creatinine clearance of the
left kidney at 4 and 5 hours after ischemia was only
slightly lower than before ischemia, but creatinine
clearances of right (intact) kidneys from untreated
and furosemide-treated animals were significantly
greater than they were before ischemia. In animals
pretreated with indomethacin, this rise in creatinine
clearance of the intact kidney was reduced, where-
as preischemic and postischemic values of the left
(ischemic) kidney from furosemide-treated animals
were not affected by indomethacin (Table 2).
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Table 2. Endogenous creatinine clearance (mllmin/g kidney wt) of right (intact) kidney from untreated rats (N = 8) and of right (intact)
and left (ischemic) kidneys from rats treated with furosemide in the absence (N = 9)or presence of indomethacin (N = 6) before and after
1-hour occlusion of the left renal arterya
Right (intact) kidney Left (ischemic) kidney
Before
After 1-hr occlusion
of left renal artery
Before
After 1-hr occlusion
of left renal artery
4 hours 5 hours 4 hours 5 hours
Untreated
Furosemide-treatedb
Furosemide +
indomethacin-treated
0.82 0.08
0.84 0.17
NS
0.59 0.08
1.46 0.20 1.44 0.19
1.56 0.23 1.69 0.23
<0.01 <0.01
0.69 0.15 0.94 0.20
0.72 0.06
0.63 0.08
NS
0.52 0.06
— —
0.49 0.18 0.42 0.11
NS NS
0.5! 0.15 0.41 0.14
a Values represent the means SEM.
Furosemide vs. furosemide + indomethacin-treated rats
Renal excretory function in untreated rats. Uri-
nary flow rate from the left kidney was 1.11 0.13
mllhr/ 100 g prior to ischemia and decreased to 0.10
0.04 mi/hr/tOO g during the first hour after 1 hour
of complete artery occlusion. It further declined to
complete anuria within 12 hours, which persisted
for 48 hours after ischemia. Urine production then
started on day 3 after ischemia and reached 0.32
0.04 mllhr/100 g on day 6. Urinary osmolality (Uosm)
of 129 10 mOsm/liter prior to ischemia became iso-
tonic to plasma after ischemia (273 5 and 250 17
mOsmlliter at 1 and 12 hours after ischemia, respec-
tively). At 72 hours after ischemia, Uosm was re-
duced to 181 10 and reached 131 37 mOsmlliter
on day 6 after ischemia. Similarly, urinary sodium
concentration of 2 1 mEq/liter prior to ischemia
approached plasma isotonicity after ischemia,
which persisted for more than 24 hours (161 11
mEq/liter). At 60 hours after ischemia, urinary so-
dium concentration declined to 83 25 mEq/liter
and reached control values on day 6 after ischemia
(4 2 mEq/liter). Urinary sodium excretion signifi-
cantly increased immediately after ischemia but
then declined to remain within the control range 12
hours to 6 days after ischemia (Fig. 1).
Renal excretory function in furosein ide-treated
animals. Prior to ischemia of the left kidney, furose-
mide significantly increased urine flow rate of this
kidney from 0.09 0.01 to 3.09 0.66 mllhr/l00 g
and sodium concentration from 49 9 to 124
mEq/liter, with urinary sodium excretion rising
from 8.8 1.7 to 362 70 .tEq/hr/lOO g and urinary
potassium excretion from 12.4 1.3 to 48.2 3.6
rEq/hr/100 g. One hour after ischemia, urine flow
was reduced to 0.30 0.10 mllhr/100 g, with a sub-
sequent rise to 1.49 0.48 mi/hr/tOO g at 5 hours
after ischemia. Similarly, urinary sodium excretion
declined to 45.2 14.4 j.tEq/hr/l00 g within 1
hour after ischemia but then rose to 216 68 .tEq/
hr/100 g after 5 hours. Potassium excretion de-
Fig. 1. Urinarvflou rate (V), osmolality (U0,,,.j, sodium concentration (UNJ, and sodium excretion (U5V)from left (ischemic) kidney in
rats before and after 1 hour of total renal artery occlusion (C = control collection period).
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Fig. 2. Urinary flow rate (V), osmolality (U0,,J, sodium (UNOV), and potassium (UKV) excretion from left (ischemic) kidney before and
after 1 hour of total renal artery occlusion in nine rats treated with furosemide (._.) and six rats treated with furosemide and indometh-
acm (o._o). C is control collection period; F1 and F2 are 1st and 2nd hour of furosemide infusion before ischemia. Asterisk denotes P <
0.05.
creased in parallel after ischemia and remained low
thereafter. Following administration of furosemide,
urinary osmolality approximated isotonic values be-
fore and after ischemia (Fig. 2). When furosemide
was stopped 36 hours after ischemia and body
weight was kept constant, urine flow rate decreased
within 6 hours to 0.55 0.19 mllhr/l00 g with the
osmolality rising to 467 48 mOsmlliter (intact
right kidney: 500 69 mOsmlliter) and a sodium
concentration of 120 35 mEq/liter (right kidney:
121 38 mEq/liter). With subsequent replacement
of 0.9% saline by infusion of 52% fructose solution,
urinary osmolality of the left kidney declined to 231
25 mOsm/liter (right kidney: 182 24 mOsmllit-
er) and sodium concentration to 47 3 mEq/liter
(right kidney: 38 3 mEq/liter) which is similar to
that of the nonischemic left kidney prior to furose-
mide. Endogenous creatinine clearance then was
0.51 0.12 mllminlg kidney wt.
Effects of prostaglandin inhibition on renal ex-
cretory function in furosemide-treated animals. Ef-
fective inhibition of PG synthesis significantly de-
creased furosemide-stimulated urinary flow rate
and sodium excretion of the intact kidney through-
out the experiments and urinary potassium excre-
tion after ischemia of the contralateral kidney (Fig.
3). Indomethacin significantly enhanced urinary os-
molality of the right (intact) kidney prior to is-
chemia and furosemide administration from 944
44 to 1302 115 mOsm/liter and during the initial
phase of furosemide infusion, but, except for the
last urine collection period, it had no effect on un-
nary isotonicity induced by furosemide. Although
there was a similar tendency to decrease urinary
flow rate and sodium excretion with a significant (P
< 0.05) increase in urinary osmolality prior to is-
chemia, no significant effects of PG inhibition on
urinary flow, osmolality, sodium, or potassium ex-
cretion of the left ischemic kidney were noted (Fig.
2).
Discussion
Various experimental models in different animal
species have been used in the past to investigate the
mechanisms underlying the events of acute renal
failure. These have included induction of renal fail-
ure by toxic agents such as glycerol [31, 32], mer-
curic chloride [11], uranyl nitrate [33, 34], and anti-
biotics [3, 6]. In some of these models of nephrotox-
ic acute renal failure, however, low normal urine
flow or polyuria, rather than an oligoanuric phase,
have been observed [Il, 32, 34—38]. Circulatory
renal failure has been induced by potent vasocon-
strictor agents such as norepinephrine [10] or by me-
chanical occlusion of the renal artery [39]. Experi-
mental studies of acute renal failure have often been
performed under conditions of micropuncture, that
is, in anesthetized animals, despite the fact that
anesthetics are known to affect total renal plasma
flow, intrarenal blood flow distribution [40], GFR
and urinary sodium excretion [41]. It therefore ap-
peared necessary to study functional changes of
acute renal failure in conscious animals. Because
more than 70% of acute renal failure in man is due
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to circulatory failure [2], in the present study 1 hour
of total occlusion of the renal artery was used to
experimentally induce acute renal failure [39]. To
avoid uremic intoxication of the animals and to
eliminate extrarenal changes of the internal envi-
ronment during long-term observation, as well as to
use one kidney as the animals' own control, we
chose the model of unilateral ischemic renal failure
[39] with the contralateral kidney left intact.
As demonstrated by our results, this model ap-
pears to be a suitable type of experimental renal
failure with functional changes closely resembling
those observed in man, at least with regard to the
early phase of oligoanuria and the subsequent re-
covery of renal function. Because controversial re-
suits regarding the validity of conventional clear-
ance measurements in experimental acute renal fail-
ure due to leakage [42] of indicator substances
across tubular epithelium [43] were reported, we did
not try to determine hippuran clearance in this
study. In group 1 animals with oligoanuria, low
urine flow rates from the left kidney following is-
chemia also did not permit determination of urinary
creatinine concentrations for comparison of creati-
nine clearances between control and furosemide-
treated animals at 4 and 5 hours after ischemia. Pre-
vious studies, however, have indicated that inulin
clearance following 1 hour of unilateral or bilateral
renal artery occlusion in the rat decreased within 10
mm after release of the arterial clamp by more than
75% [44—46] and was still less than 10% of control
by day 3 [47, 48]. The time sequence of changes in
GFR thus reported in the literature is compatible
with the changes in water and electrolyte excretion
observed in the present study during a followup pe-
riod of 6 days. They revealed an early phase of
tubular injury, with urinary sodium concentrations
approaching plasma isotonicity and high rates of
urinary sodium excretion despite the rapid decline
in urinary flow with oligoanuria, which persisted for
approximately 48 hours. Urinary sodium excretion
then sharply declined, probably because of the de-
crease in filtered load of sodium, a mechanism pre-
viously considered to protect body salt and water
homeostasis from excessive sodium losses [49]. At
60 hours after ischemia, urine flow began to rise,
and urinary sodium concentration decreased con-
tinuously to reach control values on day 6. Thus,
after an early phase of salt wasting, urinary sodium
excretion persistently remained within the normal
range. The increase in urine flow and decrease in
urinary osmolality below isosmotic values with nor-
mal urinary sodium concentration demonstrate re-
covery from tubular damage and indicate that the
kidney regained its ability to absorb sodium. Al-
though clearance studies were not performed in this
type of long-term observation, we may speculate,
that GFR also increased with improvement of tubu-
lar function after the third postischemic day.
For the protective effect of furosemide, con-
troversial results have been obtained so far in dif-
ferent experimental models of acute renal failure.
Failure to prevent renal functional loss may in part
have occurred because of failure to replace volume
losses induced with administration of this drug [5].
In contrast, several studies have demonstrated that
furosemide in fact may protect from oliguric renal
failure [7—Il] by mechanisms not yet recognized.
The present results demonstrate that in the rat fu-
rosemide may prevent oliguric acute ischemic renal
failure when administered before and after com-
plete interruption of renal perfusion. Thus, a de-
cline in urine flow was only observed during a peri-
od of less than 1 hour. In furosemide-treated ani-
mals, creatinine clearances of the left kidney before
ischemia were slightly but not significantly lower
than those of the right kidney. Although the ureteral
catheter (PE-lO) was much shorter than that used
by Cortell et al [50], a minor effect on intrarenal
pressure cannot be excluded, which, however, does
not invalidate the observed effects of furosemide in
the absence and presence of indomethacin. Bearing
in mind the above cited pitfalls of clearance mea-
surements with conventional methods [42, 43], note
that endogenous creatinine clearance of the left kid-
ney 4 and 5 hours after ischemia was only slightly
lower than before ischemia and was unaffected by
treatment with indomethacin. In addition, when in-
fusion of furosemide was stopped 36 hours after is-
chemia, at a time when renal failure in untreated
animals was still complete, creatinine clearance was
0.51 mL'minlg kidney wt; and the rise in urinary os-
molality to 467 mOsm/liter during saline infusion
and the decline in urinary sodium concentration to
47 mEq/liter during fructose infusion indicate that
tubular absorption of sodium and water were at
least partially preserved.
This protective effect of furosemide cannot be
due to a preischemic rise in GFR or tubular flow
rate because we have previously shown that rapid
expansion of the extracellular fluid volume with iso-
tonic saline equal to a 10% increase in body weight
[51] does not protect from oligoanuria in this model
[52]. It has been proposed that increased delivery of
sodium chloride to the distal tubule provokes the
signal of the macula densa feedback mechanism to
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C F1 F2 1 2 3 4 5 hr C F1F2 1 • 2 3' 4 5 hr
Fig. 3. Urinary flow rate (V), osmolalifl' (Uosm), sodium (U2,V and potassium (UKV) excretion from right (intact) kidney in nine rats
treated with furosemide (._.) and six rats treated with furose,nide and indomethacin (o_o) C is control collection period; F1 and F2 are
1st and 2nd hour of furosemide infusion before ischemia of the left kidney. Asterisk denotes P < 0.05; two asterisks denote P < 0.02.
increase renin release [53] and intrarenal angioten-
sin formation, which would then cause arteriolar
vasoconstriction [54] or alter glomerular per-
meability coefficient [55] via mesangial cells [56].
Although it has been suggested that furosemide may
suppress the macula densa signal and thereby pro-
tect the kidney from oliguric renal failure [12], this
diuretic may directly stimulate renin secretion by
juxtaglomerular cells [57]. We have previously
shown that high salt intake (1% saline as drinking
fluid during 6 weeks) prior to ischemic injury—as-
sumed to suppress intrarenal renin synthesis—did
not modify the oliguric phase of acute renal failure
in this model [52].
Because pretreatment with the angiotensin antag-
onist Sar1-A1a8-angiotensin II, which may be as-
sumed to also act on intrarenal angiotensin II recep-
tor sites [58], had no protective effect in our model
[52], a mode of action of furosemide involving a
possible effect on intrarenal angiotensin II genera-
tion also seems unlikely.
It has been suggested that prostaglandins may ex-
ert a protective effect in experimental acute renal
failure [52, 53, 60], but so far only conflicting results
have been obtained. Low renal concentrations of
PGA have been found in rats with glycerol-induced
acute renal failure [61], whereas others have report-
ed increased renal PG-concentrations in rats and
rabbits with glycerol or mercuric chloride-induced
acute tubular necrosis [62]. Intravenous administra-
tion of PGA had no effects on renal failure in the rat
when induced by uranyl-nitrate or glycerol [63]. In-
fusion of PGE, however, has been reported to exert
a protective effect on glycerol and norepinephrine-
induced renal failure in the rat [64] and dog [65, 66],
respectively, and similar results have been obtained
with bradykinin [66], the renal effects of which are
partly mediated by intrarenal prostaglandins [67]. In
the dog, renal failure following uranyl-nitrate ad-
ministration was not improved by PGE2 [65]. Inhibi-
tion of PG synthesis with indomethacin did not sig-
nificantly modify the severity of renal failure in-
duced by mercuric chloride in rat and rabbit [32, 68]
or by glycerol in the rat [61], but it deteriorated the
glycerol-induced renal failure in the rabbit [32]. The
protective effect of saline infusion in rats with
glycerol-induced renal failure was also abolished by
indomethacin [69].
As shown by others and ourselves [19, 20] (Kra-
mer et al, Clin Sci, in press), the diuresis and
natriuresis following administration of furosemide
is accompanied by a significant increase in uri-
nary excretion of PGE2, and inhibition of PG-syn-
thesis abolishes the natriuretic effects of furosemide
[70—72]. In addition, 5 hours after ischemia, urinary
PGE2 excretion from the left (ischemic) kidney was
significantly higher than before ischemia and higher
than PGE2 excretion from the right (intact) kidney
(P < 0.05), a finding compatible with the increased
PGE content of rat kidney observed by Torres et al
24 hours after initiation of acute renal failure [62].
We therefore hypothesized that enhancement of in-
trarenal activity of prostaglandins as potent vaso-
dilators [73] may be one mechanism of furosemide-
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induced protection from oliguric renal failure. This
hypothesis was indirectly investigated by con-
comitant inhibition of PG synthesis. Furosemide-
stimulated urinary PGE2 excretion significantly fell
following administration of indomethacin to values
far below the mean value during control collection
periods. It must be inferred, however, that urinary
PGE2 excretion, although most probably reflecting
intrarenal prostaglandin metabolism [74], may not
reflect activities of other tissue or vascular com-
ponents of this intrarenal hormonal system, for ex-
ample, prostacyclin [75], possibly involved in the
regulation of renal vascular resistance and elec-
trolyte excretion. Although preliminary data in ani-
mals with poorly controlled fluid balance have sug-
gested that inhibition of PG synthesis may abolish
the protective effects of furosemide [52], in the
present study effective suppression of renal PG me-
tabolism throughout the postischemic course did
not prevent furosemide-induced protection from
postischemic oliguria.
Inhibition of PG synthesis with indomethacin led,
however, to well-known effects on renal function of
the contralateral intact kidney, that is, enhanced
urinary concentrating ability [76] prior to adminis-
tration of furosernide and a significant decrease in
furosemide-induced diuresis, natriuresis, and ka-
liuresis [77] throughout the experimental course.
Also, indomethacin reduced the compensatory rise
in endogenous creatinine clearance of the intact right
kidney following ischemia of the contralateral kid-
ney, which was observed in the absence of inhibi-
tion of PG-synthesis. From these experiments, it
may be concluded that functional adaptation of the
kidney may depend to some degree on intact intra-
renal PG synthesis [68, 78]. Protection from oliguric
renal failure by furosemide, however, must depend
on mechanisms other than an activation of the renal
PG system.
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